Association between programmed cell death 6 interacting protein insertion/deletion polymorphism and the risk of breast cancer in a sample of iranian population

18Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

It has been suggested that genetic factors contribute to patients' vulnerability to breast cancer (BC). The programmed cell death 6 interacting protein (PDCD6IP) encodes for a protein that is known to bind to the products of the PDCD6 gene, which is involved in the apoptosis pathway. The aim of this case-control study is to investigate the relationship between the PDCD6IP 15 bp insertion/deletion (I/D) polymorphism (rs28381975) and BC risk in an Iranian population. A total of 491 females, including 266 BC patients and 225 control subjects without cancer, were enrolled into the study. Our findings revealed that the PDCD6IP 15 bp I/D polymorphism decreased the risk of BC in codominant (OR = 0.44, 95% CI = 0.31-0.65, p < 0.0001, I/D versus DD; OR = 0.39, 95% CI = 0.17-0.88, p = 0.030, I/I versus DD) and dominant (OR = 0.44, 95% CI = 0.30-0.63, p < 0.0001, D/I + I/I versus D/D) tested inheritance models. Also, the PDCD6IP I allele significantly decreased the risk of BC (OR = 0.59, 95% CI = 0.45-0.78, p < 0.001) compared to the D allele.

Cite

CITATION STYLE

APA

Hashemi, M., Yousefi, J., Hashemi, S. M., Amininia, S., Ebrahimi, M., Taheri, M., & Ghavami, S. (2015). Association between programmed cell death 6 interacting protein insertion/deletion polymorphism and the risk of breast cancer in a sample of iranian population. Disease Markers, 2015. https://doi.org/10.1155/2015/854621

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free